期刊文献+

甲状腺全切除术+中央区淋巴结清扫术治疗甲状腺乳头状癌中的临床效果 被引量:4

Clinical Effect of Total Thyroidectomy+Central Lymph Node Dissection in the Treatment of Papillary Thyroid Carcinoma
下载PDF
导出
摘要 目的探讨甲状腺全切除术+中央区淋巴结清扫术在甲状腺乳头状癌中的临床效果。方法以我院578例甲状腺乳头状癌患者为研究对象,将其随机分成两组,对照组(289例)单独行甲状腺全切除术治疗,观察组(289例)选择甲状腺全切除术+中央区淋巴结清扫术治疗,比较两组的临床治疗效果。结果术后随访2年,观察组淋巴结复发转移率6.23%,对照组淋巴结复发转移率20.07%,组间比较差异具有统计学意义(χ2=24.24,P<0.01);观察组术后低钙血症和声带麻痹发生率为和16.61%和14.53%,对照组分别为11.07%和11.42%,均在2个月内恢复(P>0.05)。结论甲状腺全切除术+中央区淋巴结清扫术降低了甲状腺乳头状癌术后复发率,安全性良好,值得进步推广应用。 Objective To investigate clinical effect of total thyroidectomy+central lymph node dissection in the treatment of papillary thyroid carcinoma. Methods 128 cases patients with papillary thyroid carcinoma were selected as research object. They were divided into two groups randomly. Control group(289 cases)was treated with total thyroidectomy. Observation group(289 cases)was treated with total thyroidectomy + central lymph node dissection. The clinical effect was then compared. Results After 2 years followed-up, lymph node recurrence rate of observation group was 6.23%, and lymph node recurrence rate of control group was 20.07%. The difference had statistical significance(χ2 =24.24, P〈0.01). The incidence of hypocalcemia and vocal cord paralysis of observation group were 16.61% and 14.53%, and the control group were 11.07% and 11.42%. The symptoms restored within two months. The difference had no statistical significance(P〈0.05). Conclusion Total thyroidectomy+central lymph node dissection reduces the recurrence rate of papillary thyroid cancer. It has a good safety, which is worthy of application.
作者 黎亮
出处 《中国医药指南》 2015年第13期36-37,共2页 Guide of China Medicine
关键词 甲状腺乳头状癌 甲状腺全切除术 中央区淋巴结清扫术 临床效果 Papillary thyroid carcinoma Total thyroidectomy Central lymph node dissection Clinical effect
  • 相关文献

参考文献8

二级参考文献83

  • 1高力.浅论分化性甲状腺癌的甲状腺切除范围[J].实用临床医药杂志,2004,8(3):6-7. 被引量:13
  • 2朱永学,王弘士,吴毅,嵇庆海,黄彩萍.甲状腺乳头状癌Ⅵ区淋巴结的归属[J].中华外科杂志,2004,42(14):867-869. 被引量:112
  • 3王家东,邓星程,金晓杰,张淳,周佳青,周秦毅,刘君,钱敏飞.前哨淋巴结探查在甲状腺乳头状癌外科手术中的应用[J].临床耳鼻咽喉头颈外科杂志,2007,21(12):543-544. 被引量:9
  • 4Leboulleux S,Rubino C,Baudin E,et al.Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.J Clin Endocrinol metab,2005,90:5723-5729.
  • 5Machens A,Hinze R,Thomusch O,et al.Pattern of nodal metastasis for primary and reoperative thyroid cancer.World J Surg,2002,26:22-28.
  • 6Sadowski BM,Snyder SK,Lairmore TC.Routine bilateral central lymph node clearance for papillary thyroid cancer.Surgery,2009,146:696-705.
  • 7Henry JF,Gramatica L,Denizot A,et al.Morbidity of prophylactic lymph nodedissection in the central neck area in patients with papillary thyroid carcinoma.Langenbecks Arch Surg,1998,383:167-169.
  • 8Steinmüller T,Klupp J,Wenking S,et al.Complications associated with different surgical approaches to differentiated thyroid carcinoma.Langenbecks Arch Surg,1999,384:50-53.
  • 9Sywak M,Cornford L,Roach P,et al.Routine ipsilateral level Ⅵ lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.Surgery,2006,140:1000-1007.
  • 10Roh JL,Park JY,Park CI.Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients:pattern of nodal metastasis,morbidity,recurrence,and postoperative levels of serum parathyroid hormone.Ann Surg,2007,245:604-610.

共引文献103

同被引文献22

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部